PTGS2 and breast cancer: The findings revealed aberrant levels in eight marker genes within BC specimens, namely PTGS2, BIRC3, PRKCQ, NRAS, CDH3, LRP1, FASN, and SIRT6 (depicted in Fig. 5A).